Here is how Investor'About ENMD: DEVELOPS MULTI-MECHANISM ONCOLOGY DRUGS THAT TARGET DISEASE CELLS AND THE BLOOD VESSELS THAT NOURISH THEM.
General Market Fundamental Checklist Technical Checklist View Chart

Rate A Stock:

Invalid ticker symbol.
PERFORMANCE WITHIN GROUP (ENMD)ENTREMED INC RANK WITHIN THE MEDICAL-BIOMED/BIOTECH GROUP (215 STOCKS)

Composite Rating(93) Rank within Group: 4th


EPS Rating(64) Rank within Group: 48th


Relative Strength Rating(99) Rank within Group: 1st


SMR Rating(E) Rank within Group: 112th


Acc/Dist. Rating(A) Rank within Group: 7th

Composite - Group Leaders
NTII NEUROBIOLOGICAL TECH INC ANIK ANIKA THERAPEUTICS INC EVTC EVOTEC AG ADS ENMD ENTREMED INC FACT FACET BIOTECH CORP EPS - Group Leaders
CELG Celgene Corp GILD Gilead Sciences Inc
(Added to My Stock Lists 07/06/09) CBST Cubist Pharmaceuticals AMGN Amgen Inc OSIP O S I Pharmaceuticals Relative Strength - Group Leaders
5TOS T S O Three Inc BCRX Biocryst Pharmaceuticals CTIC Cell Therapeutics Inc CVM Cel-Sci Corp DNDN Dendreon Corp SMR - Group Leaders
ALXN Alexion Pharmaceuticals CBST Cubist Pharmaceuticals GILD Gilead Sciences Inc
(Added to My Stock Lists 07/06/09) CELG Celgene Corp OSIP O S I Pharmaceuticals Acc/Dist - Group Leaders
EVTC Evotec Ag Ads NVAX Novavax Inc SVA Sinovac Biotech Ltd ONCY Oncolytics Biotech Inc SRLS Seracare Life Sciences s Business Daily ranks ENTREMED (ENMD)